AI assistant
Sending…
Viridian Therapeutics, Inc.\DE — Director's Dealing 2021
Jul 15, 2021
31894_dirs_2021-07-15_109c4f0f-d941-4923-95da-6d0e2cc9f6d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Viridian Therapeutics, Inc.\DE (VRDN)
CIK: 0001590750
Period of Report: 2021-07-14
Reporting Person: Moses Jennifer K. (Director)
More from Viridian Therapeutics, Inc.\DE
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Capital/Financing Update
2026
May 28
Regulatory Filings
2026
May 26
Capital/Financing Update
2026
May 11
Capital/Financing Update
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 5